Heslop HE - Search Results

1

Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects.

Melenhorst JJ, Leen AM, Bollard CM, Quigley MF, Price DA, Rooney CM, Brenner MK, Barrett AJ, Heslop HE. Melenhorst JJ, et al. Among authors: heslop he. Blood. 2010 Nov 25;116(22):4700-2. doi: 10.1182/blood-2010-06-289991. Epub 2010 Aug 13. Blood. 2010. PMID: 20709906 Free PMC article.

2

Reconstitution of the T cell receptor alpha beta repertoire in recipients of allogeneic BMT.

Rencher SD, Hanif I, Heslop HE, Turner VE, Brenner MK, Hurwitz JL. Rencher SD, et al. Among authors: heslop he. Bone Marrow Transplant. 1992 Dec;10(6):521-7. Bone Marrow Transplant. 1992. PMID: 1490202

3

Immunotherapy of leukemia.

Brenner MK, Heslop HE. Brenner MK, et al. Among authors: heslop he. Leukemia. 1992;6 Suppl 1:76-9. Leukemia. 1992. PMID: 1548941 Review.

4

Graft-versus-host reactions and bone-marrow transplantation.

Brenner MK, Heslop HE. Brenner MK, et al. Among authors: heslop he. Curr Opin Immunol. 1991 Oct;3(5):752-7. doi: 10.1016/0952-7915(91)90108-d. Curr Opin Immunol. 1991. PMID: 1836732

5

Homeostatic action of interleukin-4 on endogenous and recombinant interleukin-2-induced activated killer cell function.

Bello-Fernandez C, Bird C, Heslop HE, Gottlieb DJ, Reittie JE, Rill DM, Holland M, Prentice HG, Brenner MK. Bello-Fernandez C, et al. Among authors: heslop he. Blood. 1991 Mar 15;77(6):1283-9. Blood. 1991. PMID: 1900445 Free article.

6

Possible mechanism of action of interferon alpha in chronic B-cell malignancies.

Heslop HE, Brenner MK, Ganeshaguru K, Hoffbrand AV. Heslop HE, et al. Br J Haematol. 1991 Oct;79 Suppl 1:14-6. doi: 10.1111/j.1365-2141.1991.tb08111.x. Br J Haematol. 1991. PMID: 1931702 Review.

7

Graft versus leukaemia effects after marrow transplantation in man.

Brenner MK, Heslop HE. Brenner MK, et al. Among authors: heslop he. Baillieres Clin Haematol. 1991 Jul;4(3):727-49. doi: 10.1016/s0950-3536(09)90010-5. Baillieres Clin Haematol. 1991. PMID: 1958889 Review.

8

Gamma-interferon and tumor necrosis factor production after bone marrow transplantation is augmented by exposure to marrow fibroblasts infected with cytomegalovirus.

Duncombe AS, Meager A, Prentice HG, Grundy JE, Heslop HE, Hoffbrand AV, Brenner MK. Duncombe AS, et al. Among authors: heslop he. Blood. 1990 Sep 1;76(5):1046-53. Blood. 1990. PMID: 2168224 Free article.

9

Endogenously generated activated killer cells circulate after autologous and allogeneic marrow transplantation but not after chemotherapy.

Reittie JE, Gottlieb D, Heslop HE, Leger O, Drexler HG, Hazlehurst G, Hoffbrand AV, Prentice HG, Brenner MK. Reittie JE, et al. Among authors: heslop he. Blood. 1989 Apr;73(5):1351-8. Blood. 1989. PMID: 2495037 Free article.

10

In vivo induction of gamma interferon and tumor necrosis factor by interleukin-2 infusion following intensive chemotherapy or autologous marrow transplantation.

Heslop HE, Gottlieb DJ, Bianchi AC, Meager A, Prentice HG, Mehta AB, Hoffbrand AV, Brenner MK. Heslop HE, et al. Blood. 1989 Sep;74(4):1374-80. Blood. 1989. PMID: 2504308 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

422 results

Search Page

Filters